Strs Ohio Buys Shares of 85,997 Sotera Health Company $SHC

Key Points

• Strs Ohio invested $1 million in Sotera Health Company, acquiring 85,997 shares valued at approximately $1,003,000, indicating increasing institutional interest in the company.
• Recent research reports have upgraded Sotera Health’s rating, with Barclays recommending an "overweight" position and Wall Street Zen raising it to a "strong-buy," contributing to an average target price of $16.00.
• Insiders sold a total of 20,126,611 shares of Sotera Health in the last quarter, resulting in a significant decrease in their positions, while insiders still hold 47.55% of the company's stock.

Strs Ohio bought a new stake in shares of Sotera Health Company (NASDAQ:SHC - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 85,997 shares of the company's stock, valued at approximately $1,003,000.

A number of other hedge funds also recently modified their holdings of the business. Sculptor Capital LP lifted its holdings in shares of Sotera Health by 80.8% during the 1st quarter. Sculptor Capital LP now owns 9,037,511 shares of the company's stock valued at $105,377,000 after buying an additional 4,037,511 shares during the last quarter. T. Rowe Price Investment Management Inc. raised its stake in Sotera Health by 5.9% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 8,045,502 shares of the company's stock valued at $93,811,000 after purchasing an additional 450,761 shares during the last quarter. TPG GP A LLC acquired a new stake in Sotera Health during the first quarter worth about $79,126,000. Two Seas Capital LP raised its stake in shares of Sotera Health by 14.7% in the first quarter. Two Seas Capital LP now owns 3,321,136 shares of the company's stock valued at $38,724,000 after purchasing an additional 425,000 shares in the last quarter. Finally, Irenic Capital Management LP lifted its holdings in shares of Sotera Health by 7.2% during the 1st quarter. Irenic Capital Management LP now owns 3,117,226 shares of the company's stock worth $36,347,000 after acquiring an additional 208,063 shares during the period. Hedge funds and other institutional investors own 91.03% of the company's stock.

Insider Buying and Selling

In other Sotera Health news, Director Pincus & Co. Warburg sold 12,000,000 shares of Sotera Health stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $15.11, for a total value of $181,320,000.00. Following the completion of the sale, the director directly owned 61,822,952 shares in the company, valued at approximately $934,144,804.72. The trade was a 16.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Michael P. Rutz sold 126,611 shares of the company's stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $16.38, for a total transaction of $2,073,888.18. Following the transaction, the insider owned 450,204 shares in the company, valued at $7,374,341.52. This represents a 21.95% decrease in their position. The disclosure for this sale can be found here. Insiders sold 20,126,611 shares of company stock valued at $304,273,888 over the last quarter. Insiders own 55.12% of the company's stock.

Sotera Health Price Performance

Shares of NASDAQ SHC traded up $0.51 during midday trading on Monday, reaching $16.14. The company's stock had a trading volume of 1,965,648 shares, compared to its average volume of 2,484,764. The company has a debt-to-equity ratio of 4.49, a quick ratio of 2.23 and a current ratio of 2.47. Sotera Health Company has a fifty-two week low of $9.53 and a fifty-two week high of $16.99. The company has a market cap of $4.58 billion, a P/E ratio of 201.78 and a beta of 1.83. The business's 50 day moving average price is $14.31 and its two-hundred day moving average price is $12.60.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its quarterly earnings results on Friday, August 8th. The company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.03. The company had revenue of $294.34 million for the quarter, compared to analyst estimates of $275.81 million. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%.The company's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.19 EPS. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. On average, analysts forecast that Sotera Health Company will post 0.61 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on SHC shares. Barclays reiterated an "overweight" rating on shares of Sotera Health in a research note on Friday, August 8th. Wall Street Zen raised Sotera Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 16th. Four equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat.com, Sotera Health has an average rating of "Moderate Buy" and an average target price of $16.00.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.